Last $11.00 USD
Change Today +0.09 / 0.82%
Volume 1.1M
NKTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NEKTAR THERAPEUTICS (NKTR)

Nektar Therapeutics to Report Q2, 2014 on Jul 31, 2014
CapIQ 07/31/2014 9:00 PM ET
Nektar Therapeutics to Report Q1, 2014 on May 07, 2014
CapIQ 07/31/2014 9:00 PM ET
Nektar Therapeutics to Report Q4, 2013 on Feb 26, 2014
CapIQ 07/31/2014 9:00 PM ET

2013 revenues at Nektar Therapeutics totaled $148.9M USD, while annual losses equaled $1.40 per share.

Quarterly Earnings & Estimates - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Quarterly Earnings

Nektar Therapeutics reported 1st quarter 2014 losses of $0.37 per share on 05/9/2014.

Annual Earnings & Estimates - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Annual Earnings

Nektar Therapeutics reported annual 2013 losses of $1.40 per share on 02/28/2014.

Quarterly Revenues - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Quarterly Revenues

Nektar Therapeutics had 1st quarter 2014 revenues of $19.8M USD. This missed the $38.7M USD consensus estimate of the 8 analysts following the company. This was -14.1% below the prior year's 1st quarter results.

Annual Revenues - NEKTAR THERAPEUTICS (NKTR)

Actuals vs. Estimates for NEKTAR THERAPEUTICS NKTR

Nektar Therapeutics's Annual Revenues

Nektar Therapeutics had revenues for the full year 2013 of $148.9M USD. This was 83.4% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $11.00 USD +0.09

NKTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Depomed Inc $10.69 USD -0.35
Emergent Biosolutions Inc $22.45 USD +0.18
Ironwood Pharmaceuticals Inc $15.18 USD +0.08
Skyepharma PLC 246.00 GBp +0.75
Veloxis Pharmaceuticals A/S kr1.99 DKK -0.01
View Industry Companies
 

Industry Analysis

NKTR

Industry Average

Valuation NKTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.